Annual report
6788.TEDINET S100W12R
Period2024-04-01 → 2025-03-31
Filed2025-06-23
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.5bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥18.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.3bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.9bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥3.1bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.5bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.2bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥3.5bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.3bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.2bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.2bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.6bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.9bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.5bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.6bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥35.4bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥31.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥29.0bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥26.6bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥24.9bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥9.8bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.9bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥25.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥23.6bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥22.1bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥20.8bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥17.8bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.4bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥14.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.4bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥14.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.8bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥9.7bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥2.7bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.0bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.9bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥1.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥883m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥551m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥432m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥887m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥553m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥998m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥500m | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥568m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥109m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥292.41 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥280.51 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥214.78 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥250.58 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥195.45 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,125.8 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,911.21 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,743.39 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,585.01 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,239.7 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 67.8% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.4% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.5% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 69.8% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 9.7% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 9.9% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.4% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 735 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 663 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 650 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 608 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 576 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥15.8bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥15.4bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥14.0bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥12.1bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥2.2bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.4bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.6bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.2bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥2.3bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.6bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | ¥1.6bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥1.1bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.2bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥1.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥22.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥21.1bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥20.1bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.5bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥20.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.7bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥3.1bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥18.9bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥18.0bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥17.3bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥16.7bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥16.6bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥8.8bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥8.4bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥207.17 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.11 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.93 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.33 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥131.51 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥130 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥85 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥120 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,461.1 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,344.3 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,261.46 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,172.44 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,130.05 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 83.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 85.2% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.2% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 89.8% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 82.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 8.6% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.1% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.7% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,656,780 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,656,780 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 342 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 326 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 325 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 321 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 327 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2024-04-01 → 2025-03-31 | ¥15m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥1.4bn |
| Medical Relatedreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥710m |
| Medical Relatedreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥127m |
| Medical Relatedreportable segment | employees | at 2025-03-31 | 126 pure |
| Medical Relatedreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| Medical Relatedreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| Medical Relatedreportable segment | segment assets | at 2025-03-31 | ¥8.0bn |
| Medical Relatedreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥390m |
| Water Health Carereportable segment | capex | 2024-04-01 → 2025-03-31 | ¥353m |
| Water Health Carereportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥329m |
| Water Health Carereportable segment | employees | at 2025-03-31 | 609 pure |
| Water Health Carereportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥19.6bn |
| Water Health Carereportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥19.6bn |
| Water Health Carereportable segment | segment assets | at 2025-03-31 | ¥25.9bn |
| Water Health Carereportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥2.9bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥456m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥22.5bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥22.5bn |
| —segment total | segment assets | at 2025-03-31 | ¥33.9bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥3.3bn |
| Reconciling Itemsreconciling | depreciation | 2023-04-01 → 2024-03-31 | ¥14m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥1.4bn |
| Medical Relatedreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥148m |
| Medical Relatedreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥121m |
| Medical Relatedreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥2.6bn |
| Medical Relatedreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥2.6bn |
| Medical Relatedreportable segment | segment assets | at 2024-03-31 | ¥7.2bn |
| Medical Relatedreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥392m |
| Water Health Carereportable segment | capex | 2023-04-01 → 2024-03-31 | ¥281m |
| Water Health Carereportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥305m |
| Water Health Carereportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥17.8bn |
| Water Health Carereportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥17.8bn |
| Water Health Carereportable segment | segment assets | at 2024-03-31 | ¥22.9bn |
| Water Health Carereportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥2.7bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥428m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥426m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥20.4bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥20.4bn |
| —segment total | segment assets | at 2024-03-31 | ¥30.1bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥3.1bn |
| Medical Relatedreportable segment | employees | at 2025-03-31 | 4 pure |
| Water Health Carereportable segment | employees | at 2025-03-31 | 338 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,550
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 369200 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 8278900 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 82789 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 8680 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 8656780 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 82789 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 369200 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 369200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0426 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 369200 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 369200 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0426 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 1077000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 130 | |
| Number of male directors and other officers | FilingDateInstant | 6 | |
| Number of female directors and other officers | FilingDateInstant | 2 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.250 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02333-000MorisawaShinkatsuMember | 3350000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02333-000TaharaNorioMember | 12000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02333-000NishitaniYoshimiMember | 7000 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02333-000KameiMidoriMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02333-000DainiKuniyaMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02333-000KanzakiAkihikoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02333-000UchiyamaYukiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E02333-000YamagishiKenichiroMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant | 3371000 | |
| Number of male directors and other officers proposal | FilingDateInstant | 6 | |
| Number of female directors and other officers proposal | FilingDateInstant | 2 | |
| Ratio of female directors and other officers proposal | FilingDateInstant | 0.250 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02333-000MorisawaShinkatsuMember | 3350000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02333-000TaharaNorioMember | 12000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02333-000NishitaniYoshimiMember | 7000 | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02333-000KameiMidoriMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02333-000DainiKuniyaMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02333-000KanzakiAkihikoMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02333-000UchiyamaYukiMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02333-000YamagishiKenichiroMember | － | |
| Number of shares held ordinary shares information about directors and corporate auditors proposal | FilingDateInstant | 3371000 | |
| Audit fees reporting company | Prior1YearDuration | 30000000 | JPY |
| Non audit fees reporting company | Prior1YearDuration | － | JPY |
| Audit fees reporting company | CurrentYearDuration | 33000000 | JPY |
| Non audit fees reporting company | CurrentYearDuration | － | JPY |
| Audit fees consolidated subsidiaries | Prior1YearDuration | 17000000 | JPY |
| Non audit fees consolidated subsidiaries | Prior1YearDuration | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |